 | • レポートコード：MRC2102QY15320 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、138ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のトレプロスチニル薬市場について種類別（レモデュリン、ティバソ、オレニトラム）、用途別（病院、クリニック）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・トレプロスチニル薬市場の概要 ・世界の主要地域別トレプロスチニル薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のトレプロスチニル薬市場規模2015-2026：種類別（レモデュリン、ティバソ、オレニトラム） ・世界のトレプロスチニル薬市場規模2015-2026：用途別（病院、クリニック） ・トレプロスチニル薬の米国市場規模2015-2020 ・トレプロスチニル薬のヨーロッパ市場規模2015-2020 ・トレプロスチニル薬の中国市場規模2015-2020 ・トレプロスチニル薬の日本市場規模2015-2020 ・トレプロスチニル薬の東南アジア市場規模2015-2020 ・トレプロスチニル薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・トレプロスチニル薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・トレプロスチニル薬の市場動向・機会・課題 ・調査の結論 |
Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension.
North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following North America, Europe are also very important market with the consumption market share of 6.8%.
Market Analysis and Insights: Global Treprostinil Drugs Market
The global Treprostinil Drugs market size is projected to reach US$ 1290.6 million by 2026, from US$ 1237.7 million in 2020, at a CAGR of 0.7% during 2021-2026.
Global Treprostinil Drugs Scope and Market Size
The global Treprostinil Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Treprostinil Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Treprostinil Drugs market is segmented into
Remodulin
Tyvaso
Orenitram
The sales proportion of remodulin in 2018 is about 60%, and the sale proportion of Tyvaso is about 23% in 2018.
Segment by Application, the Treprostinil Drugs market is segmented into
Hospital
Clinic
The most proportion of treprostinil drugs is used for hospitals, and the proportion in 2018 is about 52%.
The Treprostinil Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Treprostinil Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Treprostinil Drugs Market Share Analysis
Treprostinil Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Treprostinil Drugs business, the date to enter into the Treprostinil Drugs market, Treprostinil Drugs product introduction, recent developments, etc.
The major vendors covered:
United Therapeutics
Novartis
Teva
1 Treprostinil Drugs Market Overview
1.1 Treprostinil Drugs Product Scope
1.2 Treprostinil Drugs Segment by Type
1.2.1 Global Treprostinil Drugs Sales by Type (2020-2026)
1.2.2 Remodulin
1.2.3 Tyvaso
1.2.4 Orenitram
1.3 Treprostinil Drugs Segment by Application
1.3.1 Global Treprostinil Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.4 Treprostinil Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Treprostinil Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Treprostinil Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Treprostinil Drugs Price Trends (2015-2026)
2 Treprostinil Drugs Estimate and Forecast by Region
2.1 Global Treprostinil Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Treprostinil Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Treprostinil Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Treprostinil Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Treprostinil Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Treprostinil Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Treprostinil Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Treprostinil Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Treprostinil Drugs Estimates and Projections (2015-2026)
2.4.3 China Treprostinil Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Treprostinil Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Treprostinil Drugs Estimates and Projections (2015-2026)
2.4.6 India Treprostinil Drugs Estimates and Projections (2015-2026)
3 Global Treprostinil Drugs Competition Landscape by Players
3.1 Global Top Treprostinil Drugs Players by Sales (2015-2020)
3.2 Global Top Treprostinil Drugs Players by Revenue (2015-2020)
3.3 Global Treprostinil Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treprostinil Drugs as of 2019)
3.4 Global Treprostinil Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Treprostinil Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Treprostinil Drugs Players (Opinion Leaders)
4 Global Treprostinil Drugs Market Size by Type
4.1 Global Treprostinil Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Treprostinil Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Treprostinil Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Treprostinil Drugs Price by Type (2015-2020)
4.2 Global Treprostinil Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Treprostinil Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Treprostinil Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Treprostinil Drugs Price Forecast by Type (2021-2026)
5 Global Treprostinil Drugs Market Size by Application
5.1 Global Treprostinil Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Treprostinil Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Treprostinil Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Treprostinil Drugs Price by Application (2015-2020)
5.2 Global Treprostinil Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Treprostinil Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Treprostinil Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Treprostinil Drugs Price Forecast by Application (2021-2026)
6 United States Treprostinil Drugs Market Facts & Figures
6.1 United States Treprostinil Drugs Sales Market Share by Company (2015-2020)
6.2 United States Treprostinil Drugs Sales Market Share by Type (2015-2020)
6.3 United States Treprostinil Drugs Sales Market Share by Application (2015-2020)
7 Europe Treprostinil Drugs Market Facts & Figures
7.1 Europe Treprostinil Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Treprostinil Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Treprostinil Drugs Sales Market Share by Application (2015-2020)
8 China Treprostinil Drugs Market Facts & Figures
8.1 China Treprostinil Drugs Sales Market Share by Company (2015-2020)
8.2 China Treprostinil Drugs Sales Market Share by Type (2015-2020)
8.3 China Treprostinil Drugs Sales Market Share by Application (2015-2020)
9 Japan Treprostinil Drugs Market Facts & Figures
9.1 Japan Treprostinil Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Treprostinil Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Treprostinil Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Treprostinil Drugs Market Facts & Figures
10.1 Southeast Asia Treprostinil Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Treprostinil Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Treprostinil Drugs Sales Market Share by Application (2015-2020)
11 India Treprostinil Drugs Market Facts & Figures
11.1 India Treprostinil Drugs Sales Market Share by Company (2015-2020)
11.2 India Treprostinil Drugs Sales Market Share by Type (2015-2020)
11.3 India Treprostinil Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Treprostinil Drugs Business
12.1 United Therapeutics
12.1.1 United Therapeutics Corporation Information
12.1.2 United Therapeutics Business Overview
12.1.3 United Therapeutics Treprostinil Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 United Therapeutics Treprostinil Drugs Products Offered
12.1.5 United Therapeutics Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Treprostinil Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis Treprostinil Drugs Products Offered
12.2.5 Novartis Recent Development
12.3 Teva
12.3.1 Teva Corporation Information
12.3.2 Teva Business Overview
12.3.3 Teva Treprostinil Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Teva Treprostinil Drugs Products Offered
12.3.5 Teva Recent Development
…
13 Treprostinil Drugs Manufacturing Cost Analysis
13.1 Treprostinil Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Treprostinil Drugs
13.4 Treprostinil Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Treprostinil Drugs Distributors List
14.3 Treprostinil Drugs Customers
15 Market Dynamics
15.1 Treprostinil Drugs Market Trends
15.2 Treprostinil Drugs Opportunities and Drivers
15.3 Treprostinil Drugs Market Challenges
15.4 Treprostinil Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Treprostinil Drugs Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Treprostinil Drugs Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Treprostinil Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Treprostinil Drugs Sales (K Units) by Region (2015-2020)
Table 5. Global Treprostinil Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Treprostinil Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Treprostinil Drugs Revenue Share by Region (2015-2020)
Table 8. Global Treprostinil Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Treprostinil Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Treprostinil Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Treprostinil Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Treprostinil Drugs (K Units) of Key Companies (2015-2020)
Table 13. Global Treprostinil Drugs Sales Share by Company (2015-2020)
Table 14. Global Treprostinil Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Treprostinil Drugs Revenue Share by Company (2015-2020)
Table 16. Global Treprostinil Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Treprostinil Drugs as of 2019)
Table 17. Global Treprostinil Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Treprostinil Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Treprostinil Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Treprostinil Drugs Players
Table 22. Global Treprostinil Drugs Sales (K Units) by Type (2015-2020)
Table 23. Global Treprostinil Drugs Sales Share by Type (2015-2020)
Table 24. Global Treprostinil Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Treprostinil Drugs Price (K Units) by Type (2015-2020)
Table 26. Global Treprostinil Drugs Sales Share by Type (2021-2026)
Table 27. Global Treprostinil Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Treprostinil Drugs Revenue Share by Type (2021-2026)
Table 29. Global Treprostinil Drugs Price (K Units) by Type (2021-2026)
Table 30. Global Treprostinil Drugs Sales (K Units) by Application (2015-2020)
Table 31. Global Treprostinil Drugs Sales Share by Application (2015-2020)
Table 32. Global Treprostinil Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Treprostinil Drugs Price (K Units) by Application (2015-2020)
Table 34. Global Treprostinil Drugs Sales (K Units) by Application (2021-2026)
Table 35. Global Treprostinil Drugs Sales Share by Application (2021-2026)
Table 36. Global Treprostinil Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Treprostinil Drugs Revenue Share by Application (2021-2026)
Table 38. Global Treprostinil Drugs Price (K Units) by Application (2021-2026)
Table 39. United States Treprostinil Drugs Sales (K Units) by Company (2015-2020)
Table 40. United States Treprostinil Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Treprostinil Drugs Sales (K Units) by Type (2015-2020)
Table 42. United States Treprostinil Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Treprostinil Drugs Sales (K Units) by Application (2015-2020)
Table 44. United States Treprostinil Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Treprostinil Drugs Sales (K Units) by Company (2015-2020)
Table 46. Europe Treprostinil Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Treprostinil Drugs Sales (K Units) by Type (2015-2020)
Table 48. Europe Treprostinil Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Treprostinil Drugs Sales (K Units) by Application (2015-2020)
Table 50. Europe Treprostinil Drugs Sales Market Share by Type (2015-2020)
Table 51. China Treprostinil Drugs Sales (K Units) by Company (2015-2020)
Table 52. China Treprostinil Drugs Sales Market Share by Company (2015-2020)
Table 53. China Treprostinil Drugs Sales (K Units) by Type (2015-2020)
Table 54. China Treprostinil Drugs Sales Market Share by Type (2015-2020)
Table 55. China Treprostinil Drugs Sales (K Units) by Application (2015-2020)
Table 56. China Treprostinil Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Treprostinil Drugs Sales (K Units) by Company (2015-2020)
Table 58. Japan Treprostinil Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Treprostinil Drugs Sales (K Units) by Type (2015-2020)
Table 60. Japan Treprostinil Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Treprostinil Drugs Sales (K Units) by Application (2015-2020)
Table 62. Japan Treprostinil Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Treprostinil Drugs Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Treprostinil Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Treprostinil Drugs Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Treprostinil Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Treprostinil Drugs Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Treprostinil Drugs Sales Market Share by Application (2015-2020)
Table 69. India Treprostinil Drugs Sales (K Units) by Company (2015-2020)
Table 70. India Treprostinil Drugs Sales Market Share by Company (2015-2020)
Table 71. India Treprostinil Drugs Sales (K Units) by Type (2015-2020)
Table 72. India Treprostinil Drugs Sales Market Share by Type (2015-2020)
Table 73. India Treprostinil Drugs Sales (K Units) by Application (2015-2020)
Table 74. India Treprostinil Drugs Sales Market Share by Application (2015-2020)
Table 75. United Therapeutics Corporation Information
Table 76. United Therapeutics Description and Business Overview
Table 77. United Therapeutics Treprostinil Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. United Therapeutics Treprostinil Drugs Product
Table 79. United Therapeutics Recent Development
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Treprostinil Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Novartis Treprostinil Drugs Product
Table 84. Novartis Recent Development
Table 85. Teva Corporation Information
Table 86. Teva Description and Business Overview
Table 87. Teva Treprostinil Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Teva Treprostinil Drugs Product
Table 89. Teva Recent Development
Table 90. Production Base and Market Concentration Rate of Raw Material
Table 91. Key Suppliers of Raw Materials
Table 92. Treprostinil Drugs Distributors List
Table 93. Treprostinil Drugs Customers List
Table 94. Treprostinil Drugs Market Key Trends
Table 95. Treprostinil Drugs Key Opportunities and Drivers
Table 96. Treprostinil Drugs Market Challenges
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Treprostinil Drugs Product Picture
Figure 2. Global Treprostinil Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Treprostinil Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Global Treprostinil Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 9. Global Treprostinil Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Treprostinil Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Treprostinil Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Treprostinil Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Treprostinil Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Treprostinil Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 15. Europe Treprostinil Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Treprostinil Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Treprostinil Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Treprostinil Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Treprostinil Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Treprostinil Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Treprostinil Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Treprostinil Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Treprostinil Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Treprostinil Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Treprostinil Drugs Players Market Share by Revenue in Treprostinil Drugs 2015 & 2019
Figure 26. Treprostinil Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Treprostinil Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Treprostinil Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Treprostinil Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Treprostinil Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Treprostinil Drugs Sales Market Share by Type in 2019
Figure 32. United States Treprostinil Drugs Sales Market Share by Type in 2019
Figure 33. Europe Treprostinil Drugs Sales Market Share by Company in 2019
Figure 34. Europe Treprostinil Drugs Sales Market Share by Type in 2019
Figure 35. Europe Treprostinil Drugs Sales Market Share by Application in 2019
Figure 36. China Treprostinil Drugs Sales Market Share by Company in 2019
Figure 37. China Treprostinil Drugs Sales Market Share by Type in 2019
Figure 38. China Treprostinil Drugs Sales Market Share by Application in 2019
Figure 39. Japan Treprostinil Drugs Sales Market Share by Company in 2019
Figure 40. Japan Treprostinil Drugs Sales Market Share by Type in 2019
Figure 41. Japan Treprostinil Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Treprostinil Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Treprostinil Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Treprostinil Drugs Sales Market Share by Application in 2019
Figure 45. India Treprostinil Drugs Sales Market Share by Company in 2019
Figure 46. India Treprostinil Drugs Sales Market Share by Type in 2019
Figure 47. India Treprostinil Drugs Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Treprostinil Drugs
Figure 50. Manufacturing Process Analysis of Treprostinil Drugs
Figure 51. Treprostinil Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
麻酔薬・鎮痛薬の世界市場レポート2020 Market Analysis and Insights: Global Anaesthetic Drugs and Pain Drugs Market The global Anaesthetic Drugs and Pain Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anaesthetic Drugs and Pain Drugs Scope and Market …- 副腎白質ジストロフィー治療薬の世界市場レポート2020 Adrenoleukodystrophy (ALD) is a rare, genetic, X-linked metabolic disorder caused by mutations in the ABCD1 gene that result in a deficiency in a peroxisomal protein called adrenoleukodystrophy protein (ALDP). Adrenoleukodystrophy (ALD) is a disease linked to the X chromosome. It is a result of fatt…
- 非ステロイド性抗炎症薬の世界市場レポート2020 Non-steroidal anti-inflammatory drugs refer to a class of drugs that do not contain glucocorticoids and have anti-inflammatory, antipyretic and analgesic effects. It is a first-line drug for the treatment of osteoarthritis and is widely used in other bone and joint diseases, rheumatic and immune dis…
- アルツハイマー病治療薬の世界市場レポート2020 Market Analysis and Insights: Global Alzheimer's Drugs Market The global Alzheimer's Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Alzheimer's Drugs Scope and Market Size The global Alzheimer's Drugs market is s…
- 急性片頭痛治療薬の世界市場レポート2020 A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Migraine is one of the most frequent disabling neurological conditions with a major impact on the patient’s quality of life. Migraine has been described as a chronic disorder that characterized with at…